JP2019514387A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514387A5
JP2019514387A5 JP2018556973A JP2018556973A JP2019514387A5 JP 2019514387 A5 JP2019514387 A5 JP 2019514387A5 JP 2018556973 A JP2018556973 A JP 2018556973A JP 2018556973 A JP2018556973 A JP 2018556973A JP 2019514387 A5 JP2019514387 A5 JP 2019514387A5
Authority
JP
Japan
Prior art keywords
snv
nucleic acid
targets
target
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018556973A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514387A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/030292 external-priority patent/WO2017190105A1/en
Publication of JP2019514387A publication Critical patent/JP2019514387A/ja
Publication of JP2019514387A5 publication Critical patent/JP2019514387A5/ja
Pending legal-status Critical Current

Links

JP2018556973A 2016-04-29 2017-04-29 胎児健康を評価するための多重/最適化ミスマッチ増幅(moma)−リアルタイムpcr Pending JP2019514387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662330044P 2016-04-29 2016-04-29
US62/330,044 2016-04-29
PCT/US2017/030292 WO2017190105A1 (en) 2016-04-29 2017-04-29 Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing fetal well being

Publications (2)

Publication Number Publication Date
JP2019514387A JP2019514387A (ja) 2019-06-06
JP2019514387A5 true JP2019514387A5 (enExample) 2020-06-18

Family

ID=60161136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018556973A Pending JP2019514387A (ja) 2016-04-29 2017-04-29 胎児健康を評価するための多重/最適化ミスマッチ増幅(moma)−リアルタイムpcr

Country Status (11)

Country Link
US (1) US20190153525A1 (enExample)
EP (1) EP3449018A4 (enExample)
JP (1) JP2019514387A (enExample)
CN (1) CN109661476A (enExample)
AU (1) AU2017258800A1 (enExample)
BR (1) BR112018072197A2 (enExample)
CA (1) CA3022548A1 (enExample)
EA (1) EA201892490A1 (enExample)
IL (1) IL262641A (enExample)
MX (1) MX2018013261A (enExample)
WO (1) WO2017190105A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
CN110177874A (zh) * 2016-11-02 2019-08-27 威斯康星州立大学医学院 用于使用错配扩增和统计方法来评估风险的方法
MX2019005199A (es) * 2016-11-02 2019-10-14 Medical College Wisconsin Inc Métodos para evaluar el riesgo usando and libre de células total y específico.
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US11773434B2 (en) 2017-06-20 2023-10-03 The Medical College Of Wisconsin, Inc. Assessing transplant complication risk with total cell-free DNA
CA3085933A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3781714B1 (en) 2018-04-14 2026-01-07 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599608A4 (en) * 2003-03-05 2007-07-18 Genetic Technologies Ltd Identification of fetal DNA and fetal cell marker in maternal plasma or serum
EP2351858B1 (en) * 2006-02-28 2014-12-31 University of Louisville Research Foundation Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
UA115321C2 (uk) * 2011-12-16 2017-10-25 Басф Агрокемікал Продактс Б.В. Спосіб та комплект для аналізу ahasl генів у рослин
WO2014143989A1 (en) * 2013-03-15 2014-09-18 Medical College Of Wisconsin, Inc. Fetal well being surveillance using fetal specific cell free dna
US20170051343A1 (en) * 2014-02-14 2017-02-23 The Board Of Regents Of The University Of Texas System Strand exchange hairpin primers that give high allelic discrimination
MX2017013878A (es) * 2015-04-30 2018-06-22 Medical College Of Wisconsin Inc Amplificación de discordancias optimizadas multiplicadas (moma) - reacción en cadena de polimerasa (pcr) en tiempo real, para evaluar el ácido desoxirribonucleico (adn) libre de celula.

Similar Documents

Publication Publication Date Title
JP2019514387A5 (enExample)
JP2022180384A5 (enExample)
JP2019518438A5 (enExample)
JP2019518437A5 (enExample)
JP2018514219A5 (enExample)
US11634761B2 (en) Quality assessment of circulating cell-free DNA using multiplexed droplet digital PCR
JP2022002508A (ja) 無細胞dnaを評価するための多重/最適化ミスマッチ増幅(moma)−リアルタイムpcr
JP2022002508A5 (enExample)
JP2019534017A5 (enExample)
JP2023528777A (ja) ドナー由来無細胞dnaの検出方法
JP2014073134A5 (ja) 標的増幅及びシークエンシングを使用した非侵襲的な胎児遺伝子型スクリーニング
JP7334122B2 (ja) 妊娠高血圧腎症に特異的な循環rnaシグネチャー
KR20220137578A (ko) 암 예후 예측방법 및 이의 조성물
US20190153525A1 (en) Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing fetal well being
CN111094593A (zh) 使用供体特异性无细胞dna来评估移植对象中的病症
BR112020006757A2 (pt) diagnóstico baseado no sistema de efetor crispr
CN112703254A (zh) 游离dna损伤分析及其临床应用
US20250346949A1 (en) Methods and kits for determining the efficiency of plasma separation from whole blood
CN105793438A (zh) 未知序列的双股线性核酸的全长扩增方法
JP2018512121A5 (enExample)
CN106030307A (zh) 用于确定基因组完整性和/或通过确定性限制位点全基因组扩增获得的dna序列的文库质量的方法和试剂盒
KR102112951B1 (ko) 암의 진단을 위한 ngs 방법
TW201512404A (zh) 預測乳癌復發之基因標記及方法
Tıplamaz et al. Presence of fetal DNA in maternal exhaled breath condensate
JP2016189746A (ja) プライマー対、プローブ、薬剤耐性c型肝炎ウイルスの検出キット、薬剤耐性c型肝炎ウイルスの検出方法およびc型肝炎の予後予測方法